Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

Blood (2023) 142 (11): 1008–1021.

https://doi.org/10.1182/blood.2023019799

Published: 2023

Includes: Supplemental data

Journal Articles

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Blood (2022) 140 (6): 594–607.

https://doi.org/10.1182/blood.2021015220

Published: 2022

Includes: Supplemental data

Journal Articles

Dimethyl Fumarate Ameliorates Graft-Versus-Host Disease By Negatively Regulating Aerobic Glycolysis in Alloreactive T-Cells

Kiyomi Mashima, MDPhD, Kazuya Sato, MDPhD, Norihito Takayama, Junko Izawa, Takashi Ikeda, MD, Kento Umino, MD, Hirofumi Nakano, MD, Daisuke Minakata, MD, Kaoru Morita, MD PhD, Chihiro Yamamoto, MD PhD, Masahiro Ashizawa, MD, Kaoru Hatano, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MDPhD, Shin-ichiro Fujiwara, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136229

Published: 2020

Journal Articles

Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease

Takashi Nagayama, MD, Shin-ichiro Fujiwara, MD PhD, Hirotomo Nakashima, MD, Shinichiro Kawaguchi, MD, Shoko Ito, MD, Kiyomi Mashima, MD, Kento Umino, MD, Daisuke Minakata, MD, Hirofumi Nakano, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Chihiro Yamamoto, MD PhD, Masahiro Ashizawa, MD, Kaoru Hatano, MD PhD, Kazuya Sato, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2019) 134 (Supplement_1): 5686.

https://doi.org/10.1182/blood-2019-122537

Published: 2019

Journal Articles

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Yasufumi Kawasaki, MD PhD, Kazuya Sato, MDPhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2018-99-111773

Published: 2018

Journal Articles

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Hirofumi Nakano, MD, Kazuya Sato, MD PhD, Hiroko Hayakawa, PhD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Kaoru Morita, MD PhD, Ryoko Yamasaki, MD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 3320.

https://doi.org/10.1182/blood-2018-99-110011

Published: 2018

Journal Articles

Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease

Yasufumi Kawasaki, Kazuya Sato, MDPhD, Hiroko Hayakawa, PhD, Norihito Takayama, PhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MDPhD, Yoshinobu Kanda, MD PhD

Blood (2017) 130 (Supplement 1): 4441.

https://doi.org/10.1182/blood.V130.Suppl_1.4441.4441

Published: 2017

Journal Articles

Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model

Blood (2016) 128 (22): 3350.

https://doi.org/10.1182/blood.V128.22.3350.3350

Published: 2016

Journal Articles

CD25 Expression Is Associated with Inferior Clinical Outcomes in Elderly Patients with Acute Myeloid Leukemia

Shin-ichiro Fujiwara, Kazuo Muroi, Raine Tatara, Kiyoshi Okazuka, Sato Kazuya, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Tadashi Nagai

Blood (2014) 124 (21): 3678.

https://doi.org/10.1182/blood.V124.21.3678.3678

Published: 2014

Journal Articles

Engineering of CD19-CAR T Cells from Non-Hodgkin Lymphoma Patients in a Closed System in Combination with Retronectin/OKT3 Stimulation

Hideto Chono, PhD, Kenichi Tahara, PhD, Ikuei Nukaya, PhD, Junichi Mineno, PhD, Eisuke Uehara, MD PhD, Tomonori Tsukahara, PhD, Ken Ohmine, MD PhD, Keiya Ozawa, MD PhD, Kazutoh Takesako, PhD

Blood (2014) 124 (21): 2446.

https://doi.org/10.1182/blood.V124.21.2446.2446

Published: 2014

Journal Articles

Profiles Of De Novo CD25-Positive Mature B-Cell Lymphomas

Shin-ichiro Fujiwara, Raine Tatara, Kiyoshi Okazuka, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Masaki Mori, Tadashi Nagai, Keiya Ozawa, MD, PhD, Kazuo Muroi, MD, PhD

Blood (2013) 122 (21): 4308.

https://doi.org/10.1182/blood.V122.21.4308.4308

Published: 2013

Journal Articles

Clinical Features of Newly Diagnosed CD25-Positive Follicular Lymphoma

Shin-ichiro Fujiwara, Kazuo Muroi, Raine Tatara, Ken Ohmine, Takahiro Suzuki, Masaki Mori, Tadashi Nagai, Akira Tanaka, Keiya Ozawa

Blood (2012) 120 (21): 1543.

https://doi.org/10.1182/blood.V120.21.1543.1543

Published: 2012

Journal Articles

Overcoming Resistance to 5-Azacytidine in Acute Myelogenous Leukemia

Piyanuch Sripayap, Tadashi Nagai, Mitsuyo Uesawa, Hiroyuki Kobayashi, Tomonori Tsukahara, Ken Ohmine, Kazuo Muroi, Gary Baley, Keiya Ozawa

Blood (2012) 120 (21): 1370.

https://doi.org/10.1182/blood.V120.21.1370.1370

Published: 2012

Journal Articles

Clinical Features of De Novo CD25-Positive Diffuse Large B-Cell Lymphoma

Shin-ichiro Fujiwara, Kazuo Muroi, Yuji Hirata, Kazuya Sato, Tomohiro Matsuyama, Ken Ohmine, Takahiro Suzuki, Katsutoshi Ozaki, Masaki Mori, M.D, Ph.D, Tadashi Nagai, MD, PhD, Keiya Ozawa, M.D, Ph.D

Blood (2011) 118 (21): 2666.

https://doi.org/10.1182/blood.V118.21.2666.2666

Published: 2011

Journal Articles

“Incidental Carcinomas” Detected by PET/CT Scans In the Patients with Malignant Lymphoma: A Single-Center Experience with 363 Patients

Kazuya Sato, MD, PhD, Katsutoshi Ozaki, MD, PhD, Tomohiro Matsuyama, MD, Ken Ohmine, MD, PhD, Takahiro Suzuki, MD, PhD, Masaki Mori, MD, PhD, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD

Blood (2010) 116 (21): 4132.

https://doi.org/10.1182/blood.V116.21.4132.4132

Published: 2010

Journal Articles

Vincristine Potentiates the Anti-Leukemia Effect of the Aurora Kinase Inhibitor VE-465 by Enhancing Apoptosis in Myeloid Leukemia Cells.

Ken Ohmine, MD, PhD, Tadashi Nagai, MD, PhD, Kozue Yoshida, MD, PhD, Shin-ichiro Fujiwara, MD, PhD, Mitsuyo Uesawa, MD, Chihiro Sakurai, MD, Keiya Ozawa, MD, PhD

Blood (2009) 114 (22): 2762.

https://doi.org/10.1182/blood.V114.22.2762.2762

Published: 2009

Journal Articles

Ectopic Expression and Role of RCAN1 in Myeloid Leukemia Cells.

Shin-ichiro Fujiwara, Tadashi Nagai, Satoru Kikuchi, Mitsuyo Uesawa, Chihiro Sakurai, Ken Ohmine, Jiro Kikuchi, Yusuke Furukawa, Keiya Ozawa

Blood (2009) 114 (22): 1274.

https://doi.org/10.1182/blood.V114.22.1274.1274

Published: 2009

Journal Articles

Clinical Analysis of Adult Acute Leukemia with Rearrangements of the 11q23/MLL: Multicenter Co-Operative Study.

Blood (2006) 108 (11): 2354.

https://doi.org/10.1182/blood.V108.11.2354.2354

Published: 2006

Journal Articles

Heme-Mediated Change in Sensitivity to Anti-Leukemia Reagents in BCR/ABL-Positive Cell Lines.

Ken Ohmine, MD, Tadashi Nagai, MD, Satoru Kikuchi, MD, Takuji Miyoshi, MD, Makiko Nakamura, B.Agr, Takahito Kondo, MD, Norio Komatsu, MD, Kazumichi Furuyama, MD, Keiya Ozawa, MD

Blood (2005) 106 (11): 4437.

https://doi.org/10.1182/blood.V106.11.4437.4437

Published: 2005

Journal Articles

Cloning and Characterization of a Tipifarnib-Resistant BCR/ABL-Positive Cell Line, K562/RR.

Takuji Miyoshi, MD, Tadashi Nagai, MD, Ken Ohmine, MD, Satoru Kikuchi, MD, Makiko Nakamura, B.Agr, Keiya Ozawa, MD

Blood (2005) 106 (11): 1527.

https://doi.org/10.1182/blood.V106.11.1527.1527

Published: 2005

NARROW

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Dimethyl Fumarate Ameliorates Graft-Versus-Host Disease By Negatively Regulating Aerobic Glycolysis in Alloreactive T-Cells

Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease

Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model

CD25 Expression Is Associated with Inferior Clinical Outcomes in Elderly Patients with Acute Myeloid Leukemia

Engineering of CD19-CAR T Cells from Non-Hodgkin Lymphoma Patients in a Closed System in Combination with Retronectin/OKT3 Stimulation

Profiles Of De Novo CD25-Positive Mature B-Cell Lymphomas

Clinical Features of Newly Diagnosed CD25-Positive Follicular Lymphoma

Overcoming Resistance to 5-Azacytidine in Acute Myelogenous Leukemia

Clinical Features of De Novo CD25-Positive Diffuse Large B-Cell Lymphoma

“Incidental Carcinomas” Detected by PET/CT Scans In the Patients with Malignant Lymphoma: A Single-Center Experience with 363 Patients

Vincristine Potentiates the Anti-Leukemia Effect of the Aurora Kinase Inhibitor VE-465 by Enhancing Apoptosis in Myeloid Leukemia Cells.

Ectopic Expression and Role of RCAN1 in Myeloid Leukemia Cells.

Clinical Analysis of Adult Acute Leukemia with Rearrangements of the 11q23/MLL: Multicenter Co-Operative Study.

Heme-Mediated Change in Sensitivity to Anti-Leukemia Reagents in BCR/ABL-Positive Cell Lines.

Cloning and Characterization of a Tipifarnib-Resistant BCR/ABL-Positive Cell Line, K562/RR.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only